Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Next Science Ltd

NXS
Current price
0.15 AUD -0.015 AUD (-9.37%)
Last closed 0.16 AUD
ISIN AU0000041329
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Australian Securities Exchange
Capitalization 43 971 296 AUD
Yield for 12 month -50.00 %
1Y
3Y
5Y
10Y
15Y
NXS
21.11.2021 - 28.11.2021

Next Science Limited engages in the research, development, and commercialization of technologies that address the issues in human health caused by biofilms, incumbent bacteria, fungus, viruses, and infections in North America, Australia, and New Zealand. It offers SURGX, an antimicrobial gel that conforms to the postoperative wound; BACTISURE wound lavage; BlastX, an antimicrobial wound gel that provides wound management by maintaining a moist wound environment, which is conducive to wound healing; and XPERIENCE for use in cleansing and removal of debris, including microorganisms from wounds. The company was founded in 2012 and is headquartered in Sydney, Australia. Address: Australia Square, Sydney, NSW, Australia, 2000

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

0.41 AUD

P/E ratio

Dividend Yield

Current Year

+51 001 983 AUD

Last Year

+25 788 936 AUD

Current Quarter

+25 717 811 AUD

Last Quarter

+28 227 749 AUD

Current Year

+34 772 434 AUD

Last Year

+18 170 474 AUD

Current Quarter

+20 516 878 AUD

Last Quarter

+20 643 446 AUD

Key Figures NXS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -12 995 731 AUD
Operating Margin TTM -52.17 %
PE Ratio
Return On Assets TTM -71.39 %
PEG Ratio
Return On Equity TTM -382.93 %
Wall Street Target Price 0.41 AUD
Revenue TTM 23 383 699 AUD
Book Value 0.024 AUD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 11.1 %
Dividend Yield
Gross Profit TTM 9 180 451 AUD
Earnings per share -0.08 AUD
Diluted Eps TTM -0.08 AUD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -57.93 %

Dividend Analytics NXS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History NXS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation NXS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 128.2051
Enterprise Value Revenue 1.0763
Price Sales TTM 1.8804
Enterprise Value EBITDA -11.0461
Price Book MRQ 3.9425

Financials NXS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators NXS

For 52 weeks

0.12 AUD 0.5 AUD
50 Day MA 0.18 AUD
Shares Short Prior Month
200 Day MA 0.27 AUD
Short Ratio
Shares Short
Short Percent